Age at first time point observation was positively associated with lyso-Gb1 levels; in GD, as in many other lysosomal storage diseases and inherited metabolic disorders in general, the younger the age at presentation (the onset of symptoms), the more severe the phenotype is [1]. This evidence concerns the gene GABBR1 and lysosomal storage disease.